world-maplogo-only

logo-only

logo-only

Glenmark Pharmaceuticals (GLENMARK.NS) Dividend: History, Dates & Yield - 2024

Dividend History

Glenmark Pharmaceuticals announced a annually dividend of ₹2.50 per ordinary share, payable on 2024-10-27, with an ex-dividend date of 2024-09-13. Glenmark Pharmaceuticals typically pays dividends one times a year, compared to ₹2.50 in 2024.

Find details on Glenmark Pharmaceuticals's dividend performance with a comprehensive history of past and upcoming payments.

Ex-Div dateDividend amountDividend typePay date
2024-09-13₹2.50annually2024-10-27
2023-09-18₹2.50annually2023-10-29
2022-09-12₹2.50annually2022-10-27
2021-09-08₹2.50annually2021-10-24
2020-09-17₹2.50annually2020-10-29
2019-09-19₹2.00annually2019-10-27
2018-09-19₹2.00annually2018-10-28
2017-09-20₹2.00annually2017-10-29
2016-08-03₹2.00annually2016-08-31
2015-09-10₹2.00annually2015-10-12

Dividend Increase

Glenmark Pharmaceuticals's dividend growth over the last five years (2020-2024) was 5.00% per year, while over the last ten years (2015-2024), it was 2.50% per year. In comparison, Lupin has seen an average growth rate of 17.97% over the past five years and Aurobindo Pharma's growth rate was 6.84%.

By comparing Glenmark Pharmaceuticals's dividend growth to other companies, investors can gain insight into how consistent its dividend strategy is and what that means for future payouts. However, dividend growth is just one factor to consider. Investors should also evaluate other metrics, such as earnings growth, payout ratio, and overall financial health, to get a full picture of Walmart's dividend sustainability and potential.

Dividend Yield

Glenmark Pharmaceuticals's current trailing twelve-month (TTM) dividend yield is 0.17%. Over the last 12 months, Glenmark Pharmaceuticals has maintained this yield, but how does it compare to similar stocks? For example, Lupin offers a yield of 0.38%, while Aurobindo Pharma provides a yield of 0.13%. Comparing similar stocks can help investors assess Glenmark Pharmaceuticals's yield and make more informed decisions.

CompanyDividend YieldAnnual DividendStock Price
Glenmark Pharmaceuticals (GLENMARK.NS)0.17%₹2.5₹1461.55
Lupin (LUPIN.NS)0.38%₹8₹2111.05
Aurobindo Pharma (AUROPHARMA.NS)0.13%₹1.5₹1158.55

Dividend Yield Calculator

Interested in purchasing Glenmark Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield and see how Walmart's consistent payouts could contribute to your long-term investment goals. Understanding your potential returns can help you make an informed decision.

Payout Ratio

Glenmark Pharmaceuticals has a payout ratio of 0.00%. In comparison, Lupin has a payout ratio of 0.00%, while Aurobindo Pharma's payout ratio is 0.00%.

It's important to note that the payout ratio is just one of many metrics investors use to assess a company's dividend sustainability and growth potential. It should be considered alongside other financial indicators such as earnings, cash flow, and debt levels to gain a complete picture of the company's financial health.

About Glenmark Pharmaceuticals

  • Global presence Operates in multiple countries and regions around the world
  • Key segments Diversified portfolio across various industries such as technology, healthcare, and consumer goods
  • Products/services Offers a range of products and services including software solutions, medical devices, and household products
  • Financial stability Strong financial performance, consistent dividend payments, and a history of profitability

Frequently Asked Question

How much is the next Glenmark Pharmaceuticals dividend?
Glenmark Pharmaceuticals's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next Glenmark Pharmaceuticals dividend. The next Glenmark Pharmaceuticals dividend will be released in September.
When is Glenmark Pharmaceuticals dividend paid?
Glenmark Pharmaceuticals pays dividends on a annually basis. The specific dates may vary each year but are generally around September. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does Glenmark Pharmaceuticals pay?
The specific amount of Glenmark Pharmaceuticals dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Glenmark Pharmaceuticals's dividend history.
Does Glenmark Pharmaceuticals stock pay dividends?
Yes, Glenmark Pharmaceuticals does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Glenmark Pharmaceuticals's dividend history.
How much dividend does Glenmark Pharmaceuticals pay?
Glenmark Pharmaceuticals paid ₹0.0 in 2025, ₹2.5 in 2024, ₹2.5 in 2023, ₹2.5 in 2022, ₹2.5 in 2021, and ₹2.5 in 2020.
How often does Glenmark Pharmaceuticals pay dividends?
Glenmark Pharmaceuticals typically pays dividends on a annually basis. This means that dividends are usually distributed 1 times a year. The specific payout dates may vary each year but generally fall around September.
What is Glenmark Pharmaceuticals's dividend yield?
The current dividend yield for Glenmark Pharmaceuticals is 0.17%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate Glenmark Pharmaceuticals's exact dividend yield.
When does Glenmark Pharmaceuticals go ex dividend?
Glenmark Pharmaceuticals's ex-dividend date for the latest dividend was on 2024-09-13. Glenmark Pharmaceuticals typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next Glenmark Pharmaceuticals dividend paid?
Glenmark Pharmaceuticals pays dividends on a annually basis, typically around September, but the exact dates can vary each year.
Will Glenmark Pharmaceuticals increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether Glenmark Pharmaceuticals will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is Glenmark Pharmaceuticals dividend per share?
Glenmark Pharmaceuticals paid ₹0.0 per share in 2025 and ₹2.5 per share in 2024. The amount of dividend per share that Glenmark Pharmaceuticals pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is Glenmark Pharmaceuticals a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Glenmark Pharmaceuticals a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Glenmark Pharmaceuticals a dividend stock?
Yes, Glenmark Pharmaceuticals is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is Glenmark Pharmaceuticals a good dividend stock?
Whether Glenmark Pharmaceuticals is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. Glenmark Pharmaceuticals has a history of paying regular dividends, which can make it attractive to income-focused investors.

Other factors to consider when evaluating Glenmark Pharmaceuticals as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does Glenmark Pharmaceuticals pay dividends monthly?
Glenmark Pharmaceuticals typically pays dividends on a annually basis.
Does Glenmark Pharmaceuticals pay dividends quarterly?
Glenmark Pharmaceuticals currently pays dividends on a annually basis.
Has Glenmark Pharmaceuticals ever paid a dividend?
Yes, Glenmark Pharmaceuticals has a history of paying dividends to its shareholders. Glenmark Pharmaceuticals is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy Glenmark Pharmaceuticals dividend stocks?
To buy Glenmark Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.

Place an order: Use the brokerage's trading platform to place an order to buy Glenmark Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does Glenmark Pharmaceuticals pay dividends 2024?
Glenmark Pharmaceuticals pays dividends on a annually basis. 2024 dividend payments are in 2024-10-27. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will Glenmark Pharmaceuticals increase its dividend in 2024?
Decisions regarding Glenmark Pharmaceuticals dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date Glenmark Pharmaceuticals dividend overview you can look into the above table of dividend history.
How Glenmark Pharmaceuticals dividend works?
The Glenmark Pharmaceuticals dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how Glenmark Pharmaceuticals's dividend process works:

1. Determination of Dividend: Glenmark Pharmaceuticals's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.

2. Dividend Declaration: Once the board approves a dividend, Glenmark Pharmaceuticals publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.

3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.

4. Payment Date: On the designated payment date, Glenmark Pharmaceuticals distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.

5. Tax Implications: Dividends received from Glenmark Pharmaceuticals are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are Glenmark Pharmaceuticals dividends paid?
Glenmark Pharmaceuticals dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:

1. Record Date: Glenmark Pharmaceuticals sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.

2. Payment Date: On the designated payment date, Glenmark Pharmaceuticals distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.

3. Currency: Glenmark Pharmaceuticals declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does Glenmark Pharmaceuticals pay dividends?
Glenmark Pharmaceuticals typically pays dividends on a annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does Glenmark Pharmaceuticals pay dividends?
The general pattern is that Glenmark Pharmaceuticals pays dividends around September. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is Glenmark Pharmaceuticals dividend safe?
The safety of Glenmark Pharmaceuticals's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.

To assess the safety of Glenmark Pharmaceuticals's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.

It is recommended to review Glenmark Pharmaceuticals's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.